The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis

To date, most new vaccines against Mycobacterium tuberculosis, including new recombinant versions of the current BCG vaccine, have usually been screened against the laboratory strains H37Rv or Erdman. In this study we took advantage of our recent work in characterizing an increasingly large panel of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Henao-Tamayo, Marcela, Shanley, Crystal A., Verma, Deepshikha, Zilavy, Andrew, Stapleton, Margaret C., Furney, Synthia K., Podell, Brendan, Orme, Ian M.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2015
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4569086/
https://ncbi.nlm.nih.gov/pubmed/26368806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0136500
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items